PROTOCOLprotocol_logs·May 7, 2026 at 04:29 PM
Thymosin Alpha-1 long-duration immune protocol
P
PubMedDaily
ADVANCED · P2
14
Twice weekly SubQ is the standard dosing from the international clinical use. Tα1's tolerability supports long-duration administration — this isn't a short-cycle peptide.
Protocol mirrors what's used in hepatitis and immune-deficient cancer adjunct trials internationally.
PROTOCOL PARAMETERS
| Compound | Dose | Frequency | Route |
|---|---|---|---|
| Thymosin Alpha-1 | 1.6mg | 2x weekly | SubQ |
Duration:12 weeks initial, extended based on biomarkers
Goals:Immune function research following international clinical dosing
RELATED COMPOUNDS
Comments (0)
No comments yet. Start the thread.
Keep Researching
Compare Prices
Vendor pricing for thymosin alpha 1
Explore Compounds
The full research database
Run the Math
Reconstitution and dosing calculators